Human TCR Tetramer-PE (HLA-A*24:02 PBF145-153-AYRPVSRNI)

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Target: PBF145-153

Product Type: Tetramer

Application: FCM

Conjugate: PE

Class: Others

Research Area: Immunology

Protocols: FCM

Host Species: Human

Immunogen: HLA-A*24:02 PBF145-153-AYRPVSRNI

Formulation: 0.5 mM EDTA, 0.2% BSA, 10 mM Tris-HCl (pH 8.0), 200 mM NaCl, and 0.09% NaN3.

Storage Temperature: Store at 2 to 8°C. Do not freeze. Minimize exposure to light.

Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.